[1] NEOG N,PHUKAN U,PUZARI M,et al. Klebsiella oxytoca and emerging nosocomial infections[J].Current Microbiology,2021,78(4):1115-1123. [2] LEE D,OH J Y,SUM S,et al.Prevalence and antimicrobial resistance of Klebsiella species isolated from clinically ill companion animals[J].Journal of Veterinary Science,2021,22(2):e17. [3] FARID E M M.Prevalence of Klebsiella species in slaughtered animals[D].Cairo:Cairo University, 2005. [4] GUNDOGAN N,CITAK S,YALCIN E.Virulence properties of extended spectrum β-lactamase-producing Klebsiella species in meat samples[J].Journal of Food Protection,2011,74(4):559. [5] 王兴国,胡萍,魏琳琳.产酸克雷伯菌毒力强弱及对小鼠机体影响的研究[J].中国卫生检验杂志,2021,31(9):1057-1060. WANG X G,HU P,WEI L L.Study on the virulence of Klebsielia oxytoca and its influence on mice[J].Chinese Journal of Health Laboratory Technology,2021,31(9):1057-1060.(in Chinese) [6] 江晓晗,胡宜,程佳,等.奶牛乳房炎源性肺炎克雷伯菌和产酸克雷伯菌的体外毒力比较研究[J].中国兽医杂志,2021,57(7):38-41. JIANG X H,HU Y,CHENG J,et al.Comparative study on virulence between Klebsiella pneumoniae and Klebsiella oxytoca isolated from bovine mastitis[J].Chinese Journal of Veterinary Medicine,2021,57(7):38-41.(in Chinese) [7] GUARDABASSI L,SCHWARZ S,LLOYD D H.Pet animals as reservoirs of antimicrobial-resistant bacteria[J]. The Journal of Antimicrobial Chemotherapy,2004,54(2):321-332. [8] 李希涛,王友诚.催产克雷伯菌院内感染(附9例报告)[J].中华传染病杂志,1996,4:60-61. LI X T,WANG Y C.Nosocomial infection with Klebsiella oxytoca (report of 9 cases)[J].Chinese Journal of Infectious Diseases,1996,4:60-61.(in Chinese) [9] 陈瑜.临床常见细菌、真菌鉴定手册[M].北京:人民卫生出版社,2009. CHEN Y.Handbook of Common Clinical Bacterial and Fungal Identification[M].Beijing:People's Medical Publishing House,2009.(in Chinese) [10] 阮紫涵,黄安雄,王秀娟,等.CLSI、EUCAST和中国耐药判定标准概述[J].生物技术通报,2022,38(9):47-58. RUAN Z H,HUANG A X,WANG X J,et al.Overview of CLSI,EUCAST and susceptibility breakpoints in China[J].Biotechnology Bulletin,2022,38(9):47-58.(in Chinese) [11] CUÉNOD A,WÜTHRICH D,SETH-SMITH H M B,et al.Whole-genome sequence-informed MALDI-TOF MS diagnostics reveal importance of Klebsiella oxytoca group in invasive infections:A retrospective clinical study[J]. Genome Medicine,2021,13(1):150. [12] HERZOG K A T,SCHNEDITZ G,LEITNER E,et al.Genotypes of Klebsiella oxytoca isolates from patients with nosocomial pneumonia are distinct from those of isolates from patients with antibiotic-associated hemorrhagic colitis[J]. Journal of Clinical Microbiology,2014,52(5):1607-1616. [13] BLAIR J,WEBBER M,BAYLAY A,et al.Molecular mechanisms of antibiotic resistance[J]. Nature Reviews Microbiology,2015,13:42-51. [14] KAZUKI H,TAKAE S,YUJIRO M,et al.Phenotypic and molecular characterization of antimicrobial resistance in Klebsiella spp.isolates from companion animals in Japan:Clonal dissemination of multidrug-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae[J]. Frontiers in Microbiology,2016,7:1021. [15] 夏前林,付亚文,滕小艳,等.肺癌骨转移患者血清NFKBIA和LETMD1的表达及诊断价值[J].中华肿瘤防治杂志,2021,28(18):1392-1397. XIA Q L,FU Y W,TENG X Y,et al.Expression and diagnostic value of serum NFKBIA and LETMD1 in lung cancer patients with bone metastasis[J].Chinese Journal of Cancer Prevention and Treatment,2021,28(18):1392-1397.(in Chinese) [16] FURUKAWA M,SOH J,YAMAMOTO H,et al.Silenced expression of NFKBIA in lung adenocarcinoma patients with a never-smoking history[J]. Acta Medica Okayama,2013,67(1):19-24. [17] JANSSENS R,STRUYF S,PROOST P,et al.Pathological roles of the homeostatic chemokine CXCL12[J].Cytokine & Growth Factor Reviews,2018,44:51-68. [18] COPERCHINI F,CHIOVATO L,CROCE L,et al.The cytokine storm in COVID-19:An overview of the involvement of the chemokine/chemokine-receptor system[J].Cytokine & Growth Factor Reviews,2020,53:25-32. [19] ROSE C E JR,SUNG S S,FU S M.Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung[J]. Microcirculation,2003,10(3/4):273-288. [20] YAN Y,CHEN R,WANG X,et al.CCL19 and CCR7 expression,signaling pathways,and adjuvant functions in viral infection and prevention[J].Frontiers in Cell and Developmental Biology,2019,7:212. [21] 翟哲,陈思,吴艳茹,等.绵羊CCL19基因启动子活性分析及其转录调控元件筛选[J].中国畜牧兽医,2022,49(4):1213-1222. ZHAI Z,CHEN S,WU Y R,et al.Analysis of promoter activity and screening of transcription regulatory elements of CCL19 gene in sheep[J].China Animal Husbandry & Veterinary Medicine,2022,49(4):1213-1222.(in Chinese) [22] 张丽瑾,罗梦珺,陈涛.CCL20及其受体CCR6在肝细胞肝癌中的作用[J].生命的化学,2021,41(4):793-798. ZHANG L J,LUO M J,CHEN T.Role of CCL20 and its receptor CCR6 in hepatocellular carcinoma[J].Chemistry of Life,2021,41(4):793-798.(in Chinese) [23] HJELMSTRM P,FJELL J,NAKAGAWA T,et al.Lymphoid tissue homing chemokines are expressed in chronic inflammation[J].American Journal of Pathology,2000,156(4):1133-1138. [24] NAGIRA M,IMAI T,HIESHIMA K,et al.Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13[J].Journal of Biological Chemistry,1997,272(31):19518. [25] HOLZMANN S,VASSILEVA G,CHEN S C,et al.Ection expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas,but not skin,of transgenic mice[J].The Journal of Immunology,2002,168(3):1001-1008. [26] 彭吉祥,王小康,林卓远,等.microRNA-126靶向PIK3R2调控肝癌细胞SMMC-7721的增殖和凋亡[J].岭南现代临床外科,2015,15(3):260-265. PENG J X,WANG X K,LIN Z Y,et al.Inhibitory effects of microRNA-126 on proliferation and apoptosis of human hepatocellular carcinoma cell line SMMC-7721 by targeting PIK3R2[J].Lingnan Modern Clinics in Surgery,2015,15(3):260-265.(in Chinese) [27] 刘宏军,顾建军,高君吟,等.FGG与FGA在吸烟所致COPD中的表达及意义[J].中国病理生理杂志,2021,37(10):1868-1875. LIU H J,GU J J,GAO J Y,et al.Expression and significance of FGG and FGA in smoke-induced COPD[J].Chinese Journal of Pathophysiology,2021,37(10):1868-1875.(in Chinese) |